The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Machine Learning Approaches to Predict 6-Month Mortality Among Patients With Cancer
Open accessAbstract
Importance: Machine learning algorithms could identify patients with cancer who are at risk of short-term mortality. However, it is unclear how different machine learning algorithms compare and whether they could prompt clinicians to have timely conversations about treatment and end-of-life preferences. Objectives: To develop, validate, and compare machine learning algorithms that use structured electronic health record data before a clinic visit to predict mortality among patients with cancer. Design, Setting, and Participants: Cohort study of 26 525 adult patients who had outpatient oncology or hematology/oncology encounters at a large academic cancer center and 10 affiliated community practices between February 1, 2016, and July 1, 2016. Patients were not required to receive cancer-directed treatment. Patients were observed for up to 500 days after the encounter. Data analysis took place between October 1, 2018, and September 1, 2019. Exposures: Logistic regression, gradient boosting, and random forest algorithms. Main Outcomes and Measures: Primary outcome was 180-day mortality from the index encounter; secondary outcome was 500-day mortality from the index encounter. Results: Among 26 525 patients in the analysis, 1065 (4.0%) died within 180 days of the index encounter. Among those who died, the mean age was 67.3 (95% CI, 66.5-68.0) years, and 500 (47.0%) were women. Among those who were alive at 180 days, the mean age was 61.3 (95% CI, 61.1-61.5) years, and 15 922 (62.5%) were women. The population was randomly partitioned into training (18 567 [70.0%]) and validation (7958 [30.0%]) cohorts at the patient level, and a randomly selected encounter was included in either the training or validation set. At a prespecified alert rate of 0.02, positive predictive values were higher for the random forest (51.3%) and gradient boosting (49.4%) algorithms compared with the logistic regression algorithm (44.7%). There was no significant difference in discrimination among the random forest (area under the receiver operating characteristic curve [AUC], 0.88; 95% CI, 0.86-0.89), gradient boosting (AUC, 0.87; 95% CI, 0.85-0.89), and logistic regression (AUC, 0.86; 95% CI, 0.84-0.88) models (P for comparison = .02). In the random forest model, observed 180-day mortality was 51.3% (95% CI, 43.6%-58.8%) in the high-risk group vs 3.4% (95% CI, 3.0%-3.8%) in the low-risk group; at 500 days, observed mortality was 64.4% (95% CI, 56.7%-71.4%) in the high-risk group and 7.6% (7.0%-8.2%) in the low-risk group. In a survey of 15 oncology clinicians with a 52.1% response rate, 100 of 171 patients (58.8%) who had been flagged as having high risk by the gradient boosting algorithm were deemed appropriate for a conversation about treatment and end-of-life preferences in the upcoming week. Conclusions and Relevance: In this cohort study, machine learning algorithms based on structured electronic health record data accurately identified patients with cancer at risk of short-term mortality. When the gradient boosting algorithm was applied in real time, clinicians believed that most patients who had been identified as having high risk were appropriate for a timely conversation about treatment and end-of-life preferences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Wright, A. A. (2008) · JAMA · doi:10.1001/jama.300.14.1665 · Cited by 2,788 · cited 2×
“Features Our data set included 3 broad classes of variables (ie, features) that are commonly available in EHRs: (1) demographic variables (eg, age and sex); (2) Elixhauser comorbidities,24 and (3) laboratory and select electrocardiogram data.”
Can machine-learning improve cardiovascular risk prediction using routine clinical data?
Weng, S. F., Reps, J., Kai, J., Garibaldi, J. M., & Qureshi, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174944 · Cited by 1,346
Relationship between cancer patients' predictions of prognosis and their treatment preferences
Weeks, J. C. (1998) · JAMA · doi:10.1001/jama.279.21.1709 · Cited by 1,319
Hoffmann, T. C., & Del Mar, C. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.8254 · Cited by 401
Cited by
Artificial intelligence in oncology: path to implementation
Chua, I. S., Gaziel‐Yablowitz, M., Korach, Z. T., Kehl, K. L., Levitan, N. A., Arriaga, Y. E., Jackson, G. P., Bates, D. W., & Hassett, M. (2021) · Cancer Medicine · doi:10.1002/cam4.3935 · Cited by 179
“35,36 Predictive analytics may aid the delivery of oncology treatments to populations that are disad-vantaged or underrepresented in clinical trials for whom it is challenging to apply evidence-based medicine.”
BackgroundUses and Limitations of Artificial Intelligence for Oncology
Kolla, L., & Parikh, R. B. (2024) · Cancer · doi:10.1002/cncr.35307 · Cited by 126
Self-citationRavaut, M., Sadeghi, H., Leung, K. K., Volkovs, M., Kornas, K., Harish, V., Watson, T., Lewis, G. F., Weisman, A., Poutanen, T., et al. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00394-8 · Cited by 121
Suh, J., Yoo, S., Park, J., Cho, S. Y., Cho, M. C., Son, H., & Jeong, H. (2020) · BJU International · doi:10.1111/bju.15122 · Cited by 45
Hsieh, P.-H., Lin, C., Lin, C.-S., Liu, W.-T., Lin, T.-K., Tsai, D.-J., Hung, Y.-J., Chen, Y.-H., Lin, C.-Y., Lin, S.-H., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01735-7 · Cited by 11
Metadata
- Authors
- Parikh, R. B., Manz, C., Chivers, C., Regli, S. H., Braun, J., Draugelis, M. E., Schuchter, L. M., Shulman, L. N., Navathe, A. S., Patel, M. S., & O’Connor, N. R.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2019-10-25
- Volume
- 2
- Issue
- 10
- Pages
- e1915997
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W2981427782
- Cited by
- 243
- References
- 6
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.